Literature DB >> 18477182

Body fat distribution, serum glucose, lipid and insulin response to meals in Alström syndrome.

R B Paisey1, D Hodge, K Williams.   

Abstract

BACKGROUND: Alström syndrome is an autosomal recessive condition characterized by obesity, insulin resistance and hypertriglyceridaemia. Responses to fat and carbohydrate ingestion are important in planning dietetic advice and may help to explain the mechanism of metabolic disorder in the syndrome.
METHODS: After a 12-h fast, five Alström subjects received a 3.1 MJ (742 kcal), 75.8% fat breakfast on day 1, and a 3.3 MJ (794 kcal), 77.5% carbohydrate breakfast on day 2. Serum glucose, triglyceride and insulin levels were measured at baseline, and 2 and 3.5 h post-meal. Abdominal computerized tomography in three subjects and magnetic resonance imaging in one demonstrated distribution of abdominal fat.
RESULTS: Body fat was distributed subcutaneously, as well as viscerally. There were no changes in serum glucose, insulin or triglycerides after the high fat meal. Triglycerides remained stable after the high carbohydrate meal but glucose and log insulin levels increased [8.4 +/- 4.1 to 13.4 +/- 6.9 mmol L(-1) (P < 0.05) and 2.6 +/- 0.27 to 3.15 +/- 0.42 pmol L(-1) (P < 0.05), respectively].
CONCLUSIONS: Dietetic advice in Alström syndrome must include calorie restriction to reduce obesity, which is predominantly subcutaneous. This study has shown that low carbohydrate advice may prove more effective than fat restriction in control of hyperglycaemia and hyperinsulinism. A single high energy meal does not exacerbate hypertriglyceridaemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18477182     DOI: 10.1111/j.1365-277X.2008.00866.x

Source DB:  PubMed          Journal:  J Hum Nutr Diet        ISSN: 0952-3871            Impact factor:   3.089


  8 in total

1.  The progression from obesity to type 2 diabetes in Alström syndrome.

Authors:  Vera Bettini; Pietro Maffei; Claudio Pagano; Sara Romano; Gabriella Milan; Francesca Favaretto; Jan D Marshall; Richard Paisey; Francesco Scolari; Nella A Greggio; Ilaria Tosetto; Jürgen K Naggert; Nicola Sicolo; Roberto Vettor
Journal:  Pediatr Diabetes       Date:  2011-07-03       Impact factor: 4.866

Review 2.  Alström syndrome: insights into the pathogenesis of metabolic disorders.

Authors:  Dorothée Girard; Nikolai Petrovsky
Journal:  Nat Rev Endocrinol       Date:  2010-12-07       Impact factor: 43.330

3.  Whole-exome sequencing establishes a diagnosis of Alstrom syndrome: a case report.

Authors:  Ziqin Liu; Xiaobo Chen
Journal:  Transl Pediatr       Date:  2022-04

4.  Alström syndrome: genetics and clinical overview.

Authors:  Jan D Marshall; Pietro Maffei; Gayle B Collin; Jürgen K Naggert
Journal:  Curr Genomics       Date:  2011-05       Impact factor: 2.236

5.  Diffuse left ventricular interstitial fibrosis is associated with sub-clinical myocardial dysfunction in Alström Syndrome: an observational study.

Authors:  Nicola C Edwards; William E Moody; Mengshi Yuan; Adrian T Warfield; Robert Cramb; Richard B Paisey; Tarekegn Geberhiwot; Richard P Steeds
Journal:  Orphanet J Rare Dis       Date:  2015-06-24       Impact factor: 4.123

6.  Cardiac magnetic resonance imaging in Alström syndrome.

Authors:  Margaret A Loudon; Nicholas G Bellenger; Catherine M Carey; Richard B Paisey
Journal:  Orphanet J Rare Dis       Date:  2009-06-10       Impact factor: 4.123

7.  Combined occurrence of diabetes mellitus and retinitis pigmentosa.

Authors:  Afaf Al-Adsani; Fadl Abdel Gader
Journal:  Ann Saudi Med       Date:  2010 Jan-Feb       Impact factor: 1.526

8.  Consensus clinical management guidelines for Alström syndrome.

Authors:  Natascia Tahani; Pietro Maffei; Hélène Dollfus; Richard Paisey; Diana Valverde; Gabriella Milan; Joan C Han; Francesca Favaretto; Shyam C Madathil; Charlotte Dawson; Matthew J Armstrong; Adrian T Warfield; Selma Düzenli; Clair A Francomano; Meral Gunay-Aygun; Francesca Dassie; Vincent Marion; Marina Valenti; Kerry Leeson-Beevers; Ann Chivers; Richard Steeds; Timothy Barrett; Tarekegn Geberhiwot
Journal:  Orphanet J Rare Dis       Date:  2020-09-21       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.